Suppr超能文献

老年患者的低级别胶质瘤:预后因素的回顾性分析

Low-grade gliomas in older patients: a retrospective analysis of prognostic factors.

作者信息

Pouratian Nader, Mut Melike, Jagannathan Jay, Lopes M Beatriz, Shaffrey Mark E, Schiff David

机构信息

Department of Neurological Surgery, University of Virginia, Box 800212, Charlottesville, VA 22908-0212, USA.

出版信息

J Neurooncol. 2008 Dec;90(3):341-50. doi: 10.1007/s11060-008-9669-3. Epub 2008 Aug 6.

Abstract

Low-grade gliomas (LGG) are increasingly being diagnosed in older patients (>or=60 years). The rising incidence is incompletely understood but demands an analysis of the natural history and prognostic factors to determine if there are differences compared to younger populations. We retrospectively review a consecutive series of 20 older patients who presented between 1991 and 2004 with LGG to characterize the presentation, management, outcomes, and prognostic factors in older patients with LGG. Median follow-up was 27.3 months. Thirty-five percent of patients harboured oligodendrogliomas. Patients presented in equal numbers with seizure, focal neurological deficit, and mental status change. Median overall survival (OS) was 27.3 months. Patients who survive beyond 2 years experience prolonged periods of progression-free survival. Younger age, seizure presentation, and radiation treatment were prognostic of OS on multivariate analysis. Similarities with previous reports of LGG suggest that age should not affect the management of LGG patients. Prospective studies of older patients with LGG are needed to further characterize the optimum management of these patients.

摘要

低级别胶质瘤(LGG)在老年患者(≥60岁)中的诊断越来越多。发病率上升的原因尚未完全明确,但需要对其自然史和预后因素进行分析,以确定与年轻人群相比是否存在差异。我们回顾性分析了1991年至2004年间连续收治的20例老年LGG患者,以描述老年LGG患者的临床表现、治疗、结局及预后因素。中位随访时间为27.3个月。35%的患者患有少突胶质细胞瘤。出现癫痫、局灶性神经功能缺损和精神状态改变的患者数量相等。中位总生存期(OS)为27.3个月。存活超过2年的患者无进展生存期延长。多因素分析显示,年龄较小、以癫痫为表现和接受放疗是OS的预后因素。与先前关于LGG的报道相似,提示年龄不应影响LGG患者的治疗。需要对老年LGG患者进行前瞻性研究,以进一步明确这些患者的最佳治疗方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验